Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 7,526–7,550 of 7,816 matching trials · page 302 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Dementia Early Recognition and Response in Primary Care NCT00866099 Educational Dementia training Runs in: United Kingdom · 2 sites |
PHASE2|PHASE3 other |
UNKNOWN | 125 | University College, London OTHER |
2010-04-19 |
|
Do HMG CoA Reductase Inhibitors Affect Abeta Levels? NCT00303277 simvastatin; pravastatin Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | 35 | Seattle Institute for Biomedical and Clinical Research OTHER |
2010-04-13 |
|
Study GSI-136 in Healthy Young and Healthy Elderly Subjects NCT00718731 GSI-136; Placebo Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 80 | Wyeth is now a wholly owned subsidiary of Pfizer INDUSTRY |
2010-04-02 |
|
Project COPE:Managing Dementia at Home NCT00259454 In-home intervention Runs in: United States · 1 site |
PHASE3 other |
COMPLETED | 278 | Thomas Jefferson University OTHER |
2010-03-16 |
|
LifeZig Personalized Reminiscence Video With Slideshows and Music for Individuals With Alzheimer's and Dementia NCT00759863 Lifezig Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 242 | Photozig, Inc. INDUSTRY |
2010-03-02 |
|
n-3 Enriched Nutrition Therapy and Postoperative Cognitive Dysfunction After Cardiac Surgery NCT00757913 n-3 enriched nutrition Runs in: Switzerland · 1 site |
PHASE4 other |
TERMINATED | 400 | University Hospital, Basel, Switzerland OTHER |
2010-02-24 |
|
Efficacy and Akathisia Incidence of Slow Infusion Metoclopramide NCT01069536 metoclopramide 10 mg |
NA other |
COMPLETED | 140 | Pamukkale University OTHER |
2010-02-17 |
|
Further Validation of the Memory Orientation Screening Test (MOST):A 5-minute Screening Test for Dementia in Primary Care Practice NCT01057602 Runs in: United States · 1 site |
NA other |
UNKNOWN | 300 | Clionsky, Mitchell, Ph.D., ABPP(CN) OTHER |
2010-02-09 |
|
Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered NCT00745576 SAM-531 Runs in: France · 1 site |
PHASE1 other |
COMPLETED | 14 | Wyeth is now a wholly owned subsidiary of Pfizer INDUSTRY |
2010-02-08 |
|
A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin NCT00990613 Dimebon IR; Dimebon Transdermal; Dimebon Transdermal; Dimebon IR; D... Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 19 | Pfizer INDUSTRY |
2010-02-03 |
|
A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020 NCT00165659 DONEPEZIL HYDROCHLORIDE Runs in: Japan · 65 sites |
PHASE2 symptomatic-cholinergic |
COMPLETED | — | Eisai Limited INDUSTRY |
2010-01-29 |
|
Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's Disease NCT01055392 Lithium Carbonate; Placebo Runs in: Brazil · 1 site |
PHASE2 other |
UNKNOWN | 80 | University of Sao Paulo OTHER |
2010-01-25 |
|
Prophylaxis Against Metoclopramide-Induced Akathisia NCT01051271 midazolam |
NA other |
COMPLETED | 225 | Pamukkale University OTHER |
2010-01-18 |
|
A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine) NCT00988624 Dimebon IR Tablet; Dimebon MR1; Dimebon MR2; Dimebon MR3; Dimebon MR4 Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 20 | Pfizer INDUSTRY |
2010-01-12 |
|
A Study of Why People With Early Memory Problems Fall or Almost Fall NCT00434889 Runs in: Canada · 1 site |
NA other |
UNKNOWN | 200 | University of Saskatchewan OTHER |
2010-01-11 |
|
A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function NCT00824590 Dimebon; Dimebon Runs in: United States · 2 sites |
PHASE1 other |
COMPLETED | 20 | Pfizer INDUSTRY |
2009-12-30 |
|
Memory Aid for Informed Consent in Alzheimer's Research NCT00105612 Memory and Organizational Aid; Standard Informed Consent Process Runs in: United States · 1 site |
NA other |
COMPLETED | 110 | National Institute on Aging (NIA) NIH |
2009-12-29 |
|
Implications of Amyloid Pathology NCT00900770 Runs in: United States · 1 site |
NA other |
UNKNOWN | 100 | National Institute on Aging (NIA) NIH |
2009-12-29 |
|
Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome NCT00965835 Runs in: United States · 1 site |
NA other |
UNKNOWN | 40 | National Institute on Aging (NIA) NIH |
2009-12-29 |
|
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia NCT00966017 Runs in: United States · 1 site |
NA other |
UNKNOWN | 108 | National Institute on Aging (NIA) NIH |
2009-12-29 |
|
A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease NCT00224497 SB-742457 Runs in: Austria; Bulgaria; Chile; Croatia; Czechia; Greece; New Z... · 48 sites |
PHASE2 other |
COMPLETED | 380 | GlaxoSmithKline INDUSTRY |
2009-12-24 |
|
Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease NCT00469456 Memantine; placebo Runs in: Australia; New Zealand; South Africa · 25 sites |
PHASE4 symptomatic-cholinergic |
COMPLETED | 265 | Forest Laboratories INDUSTRY |
2009-12-24 |
|
Predictors of Cognitive Decline in Normal Aging NCT00094939 Runs in: United States · 1 site |
NA other |
UNKNOWN | 170 | National Institute on Aging (NIA) NIH |
2009-12-14 |
|
Memory Impairment Study (Mild Cognitive Impairment Study) NCT00000173 Donepezil; Vitamin E Runs in: Canada; United States · 72 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | — | National Institute on Aging (NIA) NIH |
2009-12-11 |
|
Estrogen Hormone Protocol NCT00000177 Estrogen Runs in: United States · 25 sites |
PHASE3 other |
COMPLETED | 120 | National Institute on Aging (NIA) NIH |
2009-12-11 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial